DUBLIN, September 19, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/j8jfz4/global) has announced the addition of the "Global Transcriptomics Market 2014-2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of organism. A transcriptome represents the set of all RNA molecules, which is a small part of the genetic code. The variation in genetic expression characterizes the extensive range of physical and biochemical differences among various cells and tissues and may lead to disease. It helps researchers to understand transcriptional activity in disease cause. Transcriptomics includes four prominent technologies: Microarrays, PCR, RNAi Gene Silencing Technology, and NGS technologies.
The analysts forecast the Global Transcriptomics market will grow at a CAGR of 15.8 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Transcriptomics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used for research and diagnostics. The products employed in the use microarray, PCR, NGS and RNAi techniques are considered within the scope of the report.
The report, the Global Transcriptomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Transcriptomics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.
The increased incidence of cardiovascular, CNS disorders, and cancer leads to increased demand for improved quality tools and systems for diagnostics and drug discovery. Gene expression patterns and gene regulation mechanisms, which trigger the functioning and production of proteins, can be studied using transcriptomics, and the therapeutic target can be identified more accurately.
The increasing demand for personalized medicines, transcriptomics technologies, and continuous improvements in healthcare infrastructures is the encouraging factor for drug discovery and research. Pharmaceutical and biotechnology companies, such as F. Hoffmann-La Roche Ltd., Affymetrix, Illumina, and Abbott Laboratories, are investing a huge amount in medical research to develop strong tools and services.
According to the report, one of the major factors driving the market is the advances in transcriptomics technology. Due to improved accuracy, sensitivity, specificity, and diagnostic speed the use of transcriptomics tools is increasing.
Further, the report states that one of the major challenges is the unmet technological need for transcriptomics technologies in clinical diagnostics and research studies. For example, NGS shows limitations in the sequencing of a homopolymer region in genome sequencing, which leads to incorrect data interpretation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Application
08. Market Segmentation by Technology
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
18. Key Vendor Analysis
19. Other Reports in this Series
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Advertisement
Research and Markets (http://www.researchandmarkets.com/research/j8jfz4/global) has announced the addition of the "Global Transcriptomics Market 2014-2018" report to their offering.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of organism. A transcriptome represents the set of all RNA molecules, which is a small part of the genetic code. The variation in genetic expression characterizes the extensive range of physical and biochemical differences among various cells and tissues and may lead to disease. It helps researchers to understand transcriptional activity in disease cause. Transcriptomics includes four prominent technologies: Microarrays, PCR, RNAi Gene Silencing Technology, and NGS technologies.
The analysts forecast the Global Transcriptomics market will grow at a CAGR of 15.8 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Transcriptomics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used for research and diagnostics. The products employed in the use microarray, PCR, NGS and RNAi techniques are considered within the scope of the report.
The report, the Global Transcriptomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Transcriptomics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.
The increased incidence of cardiovascular, CNS disorders, and cancer leads to increased demand for improved quality tools and systems for diagnostics and drug discovery. Gene expression patterns and gene regulation mechanisms, which trigger the functioning and production of proteins, can be studied using transcriptomics, and the therapeutic target can be identified more accurately.
The increasing demand for personalized medicines, transcriptomics technologies, and continuous improvements in healthcare infrastructures is the encouraging factor for drug discovery and research. Pharmaceutical and biotechnology companies, such as F. Hoffmann-La Roche Ltd., Affymetrix, Illumina, and Abbott Laboratories, are investing a huge amount in medical research to develop strong tools and services.
According to the report, one of the major factors driving the market is the advances in transcriptomics technology. Due to improved accuracy, sensitivity, specificity, and diagnostic speed the use of transcriptomics tools is increasing.
Further, the report states that one of the major challenges is the unmet technological need for transcriptomics technologies in clinical diagnostics and research studies. For example, NGS shows limitations in the sequencing of a homopolymer region in genome sequencing, which leads to incorrect data interpretation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Application
08. Market Segmentation by Technology
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
18. Key Vendor Analysis
19. Other Reports in this Series
Companies Mentioned:
- Abbott Laboratories
- Affymetrix Inc.
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Biological Industries Ltd.
- Bio-Rad Laboratories Inc.
- Cytognomix Inc.
- Kreatech Inc.
- Molecular Devices LLC
- Oxford Gene Technology Ltd.
- Qiagen N. V.
- SciGene Corp.
- Sigma-Aldrich Co. LLC
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
